NASDAQ:IMCR | Cash Flow Statement | Immunocore Holdings plc

Complete source-backed cash-flow history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$808,000.00
2026-03-31$12.97M-$13.78M$1.78M$4.22M$656,000.00
2025-12-31-$30.06M-$32.66M$2.88M-$880,000.00$4.28M
2025-09-30-$177,000.00
2025-06-30-$10.3M
2025-03-31$5.02M$435,000.00$298,000.00$9.7M$2.55M
2024-12-31-$23.77M-$13.95M$3.58M-$3.54M-$51.51M
2024-09-30$8.74M
2024-06-30-$11.62M
2024-03-31-$24.44M-$4.59M$430,000.00-$430,000.00$396.01M
2023-12-31-$19.73M-$17.73M$817,000.00-$817,000.00$6.25M
2023-09-30$906,000.00
2023-06-30-$17.01M
2023-03-31-$19.45M$10.54M$3M-$3M$6.14M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$35.51M$3.1M-$10.71M$4.34M-$16.34M$12.37M
2024-12-31-$51.09M$4.2M$26.06M$5.17M-$355.13M$343.88M
2023-12-31-$55.29M$4.1M$2.94M$5.43M-$5.43M$34.35M
2022-12-31-$52.54M$5.3M-$49.21M$2.2M-$2.2M$145.44M
2021-12-31-$180.03M$7.6M-$143.11M$1.39M-$1.28M$288.19M